Compare Koninklijke Philips NV (PHG) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs VF Corp — how do they compare? Koninklijke Philips NV trades at $24.24 (market cap $23.52B), while VF Corp trades at $15 (market cap $5.71B). The key difference: Koninklijke Philips NV is far larger — about 4.1× VF Corp's market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and VF Corp for 65 Days on average.
| PHG | VFC | |
|---|---|---|
Market Cap | $23.52B | $5.71B |
Volume | 1,635,069 | 8,987,330 |
Sector | Health | Consumer Cyclical |
52-Week High | $32.91 | $21.55 |
52-Week Low | $23.81 | $12.62 |
Typical Hold Time | 84 Days | 65 Days |
Enterprise Value | $29.87B | $10.00B |
Dividend Yield | 4.17% | 2.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.30, up 0.87% with a bearish technical signal despite three consecutive quarterly earnings beats. The company shows improving fundamentals with net income turning positive at $895 million in 2025 after previous losses, supported by strong operational cash flow of $1.17 billion. Recent developments include new product launches in healthcare technology and a $33.7 million ARPA-H award for AI-enabled stroke care.
While analyst consensus leans Hold (63.64%), the improving profitability trajectory and reasonable valuation (P/E 18.94) present opportunity, though technical weakness and competitive healthcare market risks require monitoring. The stock faces resistance near $25 with support at $24, with institutional ownership showing mixed signals through recent acquisitions.
VFC trades at $14.53, up 1.04% with a bullish technical signal despite recent earnings misses. The company shows mixed fundamentals with declining revenue from $11.8B in 2022 to $9.5B in 2025, though net income is projected to recover to $274M in 2026. Valuation appears reasonable with P/E of 21.06 and P/S of 0.61, while analyst consensus leans Hold with a $18.33 price target.
The outlook remains cautious due to Vans brand weakness and execution risks, though cost-cutting and outdoor segment growth offer potential upside. Key risks include persistent revenue declines and high debt levels, while institutional sentiment is divided with 41% Buy ratings versus 52% Hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
